| 181 |
|
Design of Orally Active Dual Inhibitors of Neutral Endopeptidase and Angiotensin-Converting Enzyme with Long Duration of Action
|
Fournie-Zaluski, M.-C
|
American Chemical Society
|
1980
|
|
|
|
| 182 |
|
Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-a Converting Enzyme (TACE)/
|
Rabinowitz, M H
|
American Chemical Society
|
2001
|
|
|
|
| 183 |
|
Design of Selective Peptidomimetic Agonists for the Human Orphan Receptor BRS-3/
|
Weber, D
|
American Chemical Society
|
2003
|
|
|
|
| 184 |
|
Design of Side Chain and Main Chain Liquid Crystalline Polymers Containing Supramolecular Quasi-Rigid-Rodlike Mesogens Obtained from Collapsed Main Chain Macrocyclics
|
Percec, V
|
American Chemical Society
|
1996
|
|
|
|
| 185 |
|
Design of Specific Peptide Inhibitors for Group I Phospholipase A~2: Structure of a Complex Formed between Phospholipase A~2 from Naja naja sagittifera (Group I) and a Designed Peptide Inhibitor Val-Ala-Phe-Arg-Ser (VAFRS) at 1.9 A Resolution Reveals Uni/
|
Singh, R. K
|
American Chemical Society
|
2003
|
|
|
|
| 186 |
|
Design of Weakly Basic Thrombin Inhibitors Incorporating Novel P1 Binding Functions: Molecular and X-ray Crystallographic Studies/
|
De Simone, G
|
American Chemical Society
|
2003
|
|
|
|
| 187 |
|
Design, Parallel Synthesis, and Crystal Structures of Pyrazinone Antithrombotics as Selective Inhibitors of the Tissue Factor VIIa Complex/
|
Parlow, J. J
|
American Chemical Society
|
2003
|
|
|
|
| 188 |
|
Designs for laboratory fractionating columns /
|
Simons, J. H
|
American Chemical Society
|
1938
|
|
|
|
| 189 |
|
Design, Synthesis, and Anticancer Properties of 4,4'-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone and Analogues/
|
Morgan, L. R
|
American Chemical Society
|
2003
|
|
|
|
| 190 |
|
Design, Synthesis, and Antiviral Evaluation of 2-Chloro-5,6-dihalo-1-�D-ribofuranosylbenzimidazoles as Potential Agents for Human Cytomegalovirus Infections
|
Zou, R
|
American Chemical Society
|
1980
|
|
|
|
| 191 |
|
Design, Synthesis, and Antiviral Evaluation of 2-Substituted 4,5-Dichloro- and 4,6-Dichloro-1-�D-ribofuranosylbenzimidazoles as Potential Agentsfor Human Cytomegalovirus Infections
|
Zou, R
|
American Chemical Society
|
1980
|
|
|
|
| 192 |
|
Design, Synthesis, and Biochemical Evaluation of N-Substituted Maleimides as Inhibitors of Prostaglandin Endoperoxide Synthases
|
Kalgutkar, A. S
|
American Chemical Society
|
1980
|
|
|
|
| 193 |
|
Design, Synthesis, and Biological Activities of Cyclic Lactam Peptide Analogues of Dynorphin A(1-11)-NH~2^1
|
Lung, F.-D. T
|
American Chemical Society
|
1980
|
|
|
|
| 194 |
|
Design, Synthesis, and Biological Activities of Four Angiotensin II Receptor Ligands with gamma-Turn Mimetics Replacing Amino Acid Residues 3-5
|
Schmidt, B
|
American Chemical Society
|
1980
|
|
|
|
| 195 |
|
Design, Synthesis, and Biological Activity of a Novel Non-Cisplatin-type Platinum-Acridine Pharmacophore/
|
Martins, E T
|
American Chemical Society
|
2001
|
|
|
|
| 196 |
|
Design, Synthesis, and Biological Activity of a Potent Inhibitor of the Neuropeptidase N-Acetylated �Linked Acidic Dipeptidase
|
Jackson, P. F
|
American Chemical Society
|
1980
|
|
|
|
| 197 |
|
Design, Synthesis, and Biological Activity of Methoctramine-Related Polyamines as Putative Gi Protein Activators/
|
Melchiorre, C
|
American Chemical Society
|
2001
|
|
|
|
| 198 |
|
Design, Synthesis, and Biological Characterization of Bivalent 1-Methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole Derivatives as Selective Muscarinic Agonists/
|
Rajeswaran, W G
|
American Chemical Society
|
2001
|
|
|
|
| 199 |
|
Design, Synthesis, and Biological Evaluation of 6-Substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: A Novel Class of Diarylheterocyclic Selective Cyclooxygenase-2 Inhibitors/
|
Rao, P. N. P
|
American Chemical Society
|
2003
|
|
|
|
| 200 |
|
Design, Synthesis, and Biological Evaluation of Cytotoxic 11-Alkenylindenoisoquinoline Topoisomerase I Inhibitors and Indenoisoquinoline-Camptothecin Hybrids/
|
Fox, B. M
|
American Chemical Society
|
2003
|
|
|
|
기사
(1031)
